Propanc Health Group Corp (OTCMKTS:PPCH) announced that it would be present at the SeeThru Equity 4th MicroCap Investor conference. The company is involved in the discovery and manufacturing of different treatments for cancer patients. The conference is planned to be held at Convene Grand Central, in Midtown Manhattan on May 28. The conference is a great platform for the company to represent itself and tell its story. It is also a great opportunity for the company to meet others from its industry and find out what the others have in plan. Quite possibly, the company might be able to gain partnerships or investments for its future projects.
The CEO of the company, James Nathanielsz, and Professor Kurtz would be attending the conference on the company’s behalf. The attendance at the company is expected to be around 600 people from different industries. The company has recently been making moves up the chart, after the announcement that it is on the verge of completing of its flagship, Proenzyme drug. The drug is designed to treat and prevent certain forms of cancer.
With chemotherapy, there is always a chance for a tumor to redevelop and certain cancer cells to be left out. The consultants at PPCH target this very problem, the drugs developed by the company stop there-growth of tumors, while stopping their advancement in other parts of the body. Currently, PPCH is going to ask people with limited treatment options to come forward for the trail of their new drug. This would test the efficiency and the side effects of the drug in patients with no hope.
If Propanc Health is able to report success from its trails soon, it could prove to be a turning point for the company and it could easily rake in huge investments for further projects. The developments done by the company before this conference would be crucial. Any success at the conference would also help the company strengthen the investor’s trusts. What happens in the next two months, would probably decide in which direction the company would be expected to move for a long time.
Propanc Health Group Corp (OTCMKTS:PPCH) closed at $0.203 rising by 5.18% yesterday.